SprintRay Midas Restore: FDA-Cleared Ceramic Crown Resin for Same-Visit Dentistry

SprintRay has launched Midas Restore, a new ceramic and zirconia-filled resin that received FDA 510(k) clearance for same-visit dental restorations. The material is designed for the SprintRay Midas Digital Press and NanoCure curing system, and it covers crowns, inlays, onlays, and veneers.

The resin carries a Class II, Rx-only clearance, which means it is intended for use only by licensed dental professionals. It meets ISO 6872 standards for strength and aesthetics, with a reported mean flexural strength of 180 MPa. That puts it in the range of traditional milled zirconia and lithium disilicate restorations.

What makes this different from earlier dental resins is the filler load. SprintRay loaded Midas Restore with ceramic particles and zirconia fillers to give the final restoration a more natural translucency and polishability. The material prints on SprintRay's Midas Digital Press, which uses a single-use capsule system that combines the build platform, tank, and resin into one disposable item.

Why it matters

For patients, the appeal is obvious: walk in with a cavity or broken tooth, leave with a permanent crown the same day. For practices, the workflow eliminates lab fees and turnaround time. The catch is capital cost. The Midas Digital Press and NanoCure system is not cheap, and the per-capsule consumable cost adds up. But for busy practices doing more than a handful of crowns a week, the economics shift quickly.

The FDA clearance also signals that regulators are getting comfortable with 3D printed definitive restorations. This is not a temporary crown material. It is meant to last years inside the mouth under heavy chewing loads.

The competitive picture

SprintRay now sits alongside EnvisionTEC (now ETEC), Formlabs, and Dentsply Sirona in the same-visit restoration race. Formlabs has its Temporary A and B materials, but a definitive ceramic crown resin is a different animal. SprintRay's move closes a gap that left many practices still sending cases off to milling labs.

Whether Midas Restore gains traction will depend on clinical data, insurance coding, and dentist training. But the technology path is clear: chairside 3D printing of permanent restorations is no longer experimental.